Milestone announces acceptance of MAA by EMA for etripamil nasal spray
Milestone Pharmaceuticals (MIST) announced the acceptance of a Marketing Authorization Application, MAA, by the European Medicines Agency, EMA,…
Corcept Receives Complete Response Letter for Relacorilant as a Treatment for Patients with Hypercortisolism
REDWOOD CITY, Calif., December 31, 2025–(BUSINESS WIRE)–Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery…
High-Dose Wegovy Takes Aim at Lilly’s Zepbound
This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO) said its high-dose version of Wegovy has received a…
Zoetis (ZTS) Gains Positive Opinion For Portela Therapy In EU For Cat OA Pain Relief
Zoetis recently received a positive opinion from the European Medicines Agency’s CVMP for its pain relief therapy, Portela,…
Developmental drug for feline pain takes a step forward in Europe
A developmental drug targeting pain associated with feline osteoarthritis (OA) has received a positive opinion from the European…
EU Grants Conditional Approval of Mirdametinib for NF1-Associated Plexiform Neurofibromas
NF1-Associated PNs | Image Credit: © Dr_Microbe – stock.adobe.com The European Commission has granted conditional marketing authorization for…